Free Republic

Remdesivir[The following is a chapter of Lori Weintz’s book, Mechanisms of Harm: Medicine in the Time of Covid-19.]Tragically, the government-backed mechanical (ventilators) and pharmaceutical (remdesivir, mRNA shots, etc) interventions didn’t work to remedy the respiratory illness problem. Instead, they added an additional layer of chaos on top of the virus mania that had captured the world.Jordan SchachtelInvestigative journalistDecember 13, 2023 In the interview with Zuckerberg, in addition to mentioning HCQ, Fauci said, “There’s a drug called remdesivir, which is…developed by Gilead as an antiviral. We tried it in Ebola. It didn’t work as well as some of the other drugs,...

The initial results from a placebo-controlled trial of hydroxychloroquine for COVID-19 indicate that patients hospitalized with mild illness recovered more quickly with addition of the drug than with placebo at the start of a standard treatment. The results also suggest that hydroxychloroquine might convey some protection against the illness worsening. Zhan Zhang, MD, of Renmin Hospital of Wuhan University, Wuhan, China, and colleagues reported results from 62 patients randomized to receive either placebo or hydroxychloroquine 200mg twice daily for 5 days on admission in addition to standard treatment consisting of oxygen therapy, and unspecified regimens that could include antiviral and...

Doctor, former Kansas governor says coronavirus patients 'doing better' in testing with anti-malaria drug Dr. Jeff Colyer on the effectiveness of hydroxychloroquine to treat COVID-19 President Trump calls the malaria drug hydroxychloroquine a ‘game changer’ in treating the coronavirus; reaction and analysis from former Kansas governor, practicing surgeon Dr. Jeff Colyer. Anti-malaria drugs ike hydroxychloroquine -- which are being used to treat coronavirus (COVID-19) patients -- are showing positive results, former Kansas governor and practicing surgeon Dr. Jeff Colyer said Wednesday. Appearing on "America's Newsroom" with host Ed Henry, Colyer said that data from testing at the University of Kansas...